ASM8 inhaled
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASM8 inhaled, covering 2012-12-03 to 2012-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma [Phase 2]